ArticleCancer management and research2022

Anti-PD-1 Therapy is Beneficial for the Survival of Patients with Oral Squamous Cell Carcinoma.

Liang Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.